RxDoctor Payments Data

Kazi Hassan, MD

Interventional Pain Medicine · St Petersburg, FLNPI 1801909296

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $866 of the $1,219 with a category attached, or 71.0%. 10 manufacturers reported payments, led by Curonix LLC at 44.6% of the total. 2025 is the largest year on record at $509, more than ten times the $34 reported in 2020. That places this record below the midpoint for interventional pain medicine clinicians in FL, where the typical reported total is $4,625.

$1,219in general payments, 2019–2025

Across 42 payments — averaging $29.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Curonix LLC$544
  • Medtronic$285
  • Scilex Pharmaceuticals Inc.$153
  • Boston Scientific$125
  • Abbott$24
  • Si-bone, Inc.$23
  • plus $66 from 4 others
$3,000in research payments, 2019–2025

Across 1 payment — averaging $3000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GRT US Holding, Inc.$3K

What the payments were for

  • Travel & lodging$18415%
  • Food & beverage$86671%
  • Education$16914%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,219 in reported general payments places this provider in the 25th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$160,745
Medicare patients
208
Services billed
1,551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate59$37,889
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen649$23,898
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen531$13,037
BelbucaBuprenorphine Hcl17$12,517
OxycontinOxycodone Hcl23$8,532
Aimovig AutoinjectorErenumab-Aooe12$8,526
Pregabalin271$8,379
Oxycodone Hcl401$7,733
Gabapentin492$6,416
Lidocaine71$4,968
Diclofenac Sodium116$4,539
Morphine Sulfate ErMorphine Sulfate210$4,404
Tizanidine Hcl210$2,180
Cyclobenzaprine Hcl266$1,870
Buprenorphine19$1,679

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in St Petersburg

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →